Schaper Benz & Wise Investment Counsel’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-15,018
Closed -$217K 148
2023
Q4
$217K Sell
15,018
-2,579
-15% -$35.1K 0.02% 127
2023
Q3
$305K Sell
17,597
-30,016
-63% -$626K 0.03% 118
2023
Q2
$991K Sell
47,613
-3,976
-8% -$86.4K 0.1% 92
2023
Q1
$1.21M Sell
51,589
-3,702
-7% -$99.4K 0.12% 89
2022
Q4
$1.54M Sell
55,291
-1,493
-3% -$38.2K 0.16% 85
2022
Q3
$1.33M Buy
56,784
+648
+1% +$19.6K 0.15% 86
2022
Q2
$1.9M Sell
56,136
-5,690
-9% -$199K 0.2% 81
2022
Q1
$2.16M Sell
61,826
-2,158
-3% -$73.8K 0.19% 85
2021
Q4
$1.95M Buy
63,984
+1,685
+3% +$54.9K 0.16% 89
2021
Q3
$2.04M Buy
62,299
+42,502
+215% +$1.36M 0.18% 82
2021
Q2
$599K Buy
+19,797
New +$652K 0.05% 97

Other funds holding OGN

Schaper Benz & Wise Investment Counsel's OGN Position: Q1 2024 in Review

Schaper Benz & Wise Investment Counsel sold out of Organon & Co (OGN) in Q1 2024, closing a stake of 15,018 shares — an estimated $217K sold.

Schaper Benz & Wise Investment Counsel first reported a position in OGN in Q2 2021 and held it in 11 quarters. The position peaked at $2.16M in Q1 2022. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2024.

  • Schaper Benz & Wise Investment Counsel reported no remaining Organon & Co position as of Q1 2024 after selling out during the quarter.
  • Schaper Benz & Wise Investment Counsel sold 15,018 Organon & Co shares in Q1 2024, an estimated $217K.
  • Schaper Benz & Wise Investment Counsel first reported a position in Organon & Co in Q2 2021 and held it in 11 quarters.
  • Schaper Benz & Wise Investment Counsel's Organon & Co position peaked at $2.16M in Q1 2022.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2024.

Based on Schaper Benz & Wise Investment Counsel's 13F filing for Q1 2024, filed 29 Apr 2024.